✦ LIBER ✦

Oestrogen metabolite linked to cancer risk of some hormone replacements

✍ Scribed by Hannah Wunsch

Book ID: 117297044
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 110 KB
Volume: 351
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)78327-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current Hormone Therapy Use Linked to 30

Current Hormone Therapy Use Linked to 30-100% Rise in Risk of Breast Cancer

✍ S. London 📂 Article 📅 2004 🏛 Guttmacher Institute 🌐 English ⚖ 311 KB

Reduced risk of oestrogen receptor posit

Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy

✍ Katharine H. Sharpe; Paula McClements; Douglas I. Clark; Joanne Collins; Anthea 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Hormone Replacement Therapy: The Debate

Hormone Replacement Therapy: The Debate over the Risks and Benefits To Women, from Breast Cancer To Quality of Life

✍ Gusdal, Deanne 📂 Article 📅 2006 🏛 Elsevier Science ⚖ 113 KB

Breast cancer risk in relation to differ

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

✍ Agnès Fournier; Franco Berrino; Elio Riboli; Valérie Avenel; Françoise Clavel-Ch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 96 KB 👁 2 views

## Abstract Most epidemiological studies have shown an increase in breast cancer risk related to hormone replacement therapy (HRT) use. A recent large cohort study showed effects of similar magnitude for different types of progestogens and for different routes of administration of estrogens evaluat

Reply to Comment on: Interaction of horm

Reply to Comment on: Interaction of hormone replacement therapy with calcium and Vitamin D supplementation on colorectal cancer risk

✍ Eric L. Ding; Edward L. Giovannucci 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 66 KB

Assess the risk of breast cancer for a w

Assess the risk of breast cancer for a woman aged 52 years who wishes to commence hormone replacement therapy (HRT)

✍ Peter Bowen-Simpkins 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 108 KB